Early this month the U.S. Senate passed an amendment to pending legislation that has the potential to strengthen and streamline regulations governing the clinical testing of drugs for neglected diseases in the developing world. The targeted diseases include malaria and TB, which annually kill an estimated 2.5 million people in the developing world, plus scores of diseases you may have never heard of (such as Chagas disease and leishmaniasis), but that nonetheless exact a large and lethal toll, especially on children and poor people in developing countries.
CGD Policy Blogs
Will We Soon Have an Effective Vaccine against HIV? Not Until We Can Make a Superman or a Bionic Woman
World AIDS Vaccine Day was May 18. Where do we stand? As an economist, I’m going a bit out on a limb here, blogging about biology. Hopefully blog readers will correct my worst errors. But here’s my read …